These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 778275)

  • 1. Affinity chromatography. A new technique for partial purification of human leucocyte migration inhibitory factor.
    Bendtzen K
    J Immunol Methods; 1976; 11(2):147-51. PubMed ID: 778275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial purification of guinea pig MIF by affinity column chromatography using macrophages.
    Onozaki K; Haga S; Miura K; Hashimoto T
    Microbiol Immunol; 1979; 23(6):533-41. PubMed ID: 114736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human leukocyte migration inhibitory factor (LIF) by alpha-L-fucose.
    Bendtzen K
    Acta Allergol; 1975 Dec; 30(6):327-38. PubMed ID: 1106109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycolipid affinity purification of migration inhibitory factor.
    Liu DY; David JR; Remold HG
    Nature; 1982 Mar; 296(5852):78-80. PubMed ID: 7038511
    [No Abstract]   [Full Text] [Related]  

  • 5. Leucocyte migration inhibitory activity (LMIA) on concanavalin A (Con-A) stimulated human lymphocytes. Comparison of leucocyte migration capillary technique (LMCT), leucocyte migration agarose technique (LMAT), and leucocyte migration fibrinolysis technique (LMFT).
    Coeugniet E; Bendixen G
    Acta Pathol Microbiol Scand C; 1976 Dec; 84C(6):485-8. PubMed ID: 793298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nonspecific inhibitor of macrophage migration in cell-free ascites of rat Zajdela hepatoma. II. Biochemical characterization and purificaton.
    Fahlbusch B; Zschiesche W
    Acta Biol Med Ger; 1981; 40(6):793-800. PubMed ID: 7034428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. III. Generation of monoclonal antibody specific for human MIF.
    Fahlbusch B; Schumann I
    Biomed Biochim Acta; 1987; 46(5):397-406. PubMed ID: 3311040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on guinea-pig macrophage migration inhibitory factor (MIF). I. Glycoprotein nature and net charge.
    Kotkes P; Pick E
    Clin Exp Immunol; 1979 Sep; 37(3):532-9. PubMed ID: 228883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biochemical and biological characterization of macrophage migration inhibition factor isolated from fetal calf serum by affinity chromatography.
    Fox RA; MacSween JM; Rajaraman R
    Dev Comp Immunol; 1978 Feb; 2(1):147-60. PubMed ID: 346404
    [No Abstract]   [Full Text] [Related]  

  • 11. Chicken buffy coat leucocytes (BCL) as indicator cells for human leucocytes migration inhibitory factor (LIF).
    Bellina L; Salerno A
    J Immunol Methods; 1981; 43(3):277-81. PubMed ID: 7019345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte migration inhibitory factor (LIF). II. Partial biochemical characterization of the substrate specificities for this lymphokine.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):133-40. PubMed ID: 322260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The isolation of migration inhibition factor.
    Fox RA; MacSween JM
    Immunol Commun; 1974; 3(4):375-89. PubMed ID: 4618548
    [No Abstract]   [Full Text] [Related]  

  • 14. Affinity chromatography and separation of the molecular forms of monkey brain alpha-L-fucosidase on fucose-linked sepharose.
    Alam T; Balasubramanian AS
    Biochim Biophys Acta; 1979 Feb; 566(2):327-34. PubMed ID: 33716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of tilorone-induced mouse migration inhibitory factor by affinity chromatography and isoelectric focusing.
    Fahlbusch B; Zschiesche W; Römer W
    Acta Biol Med Ger; 1981; 40(2):147-52. PubMed ID: 7023160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte migration inhibitory factor (LIF) III. Further investigations on the serine protease nature of this lymphokine and its preference for arginine amides.
    Bendtzen K
    Scand J Immunol; 1977; 6(10):1055-62. PubMed ID: 335493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some physicochemical properties of human leucocyte migration inhibitory factor (LIF).
    Bendtzen K
    Acta Pathol Microbiol Scand C; 1976 Dec; 84C(6):471-6. PubMed ID: 11637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of human macrophage migration inhibitory factor: evidence for specific binding to glutathione and formation of subunit structure.
    Nishihira J; Kuriyama T; Nishino H; Ishibashi T; Sakai M; Nishi S
    Biochem Mol Biol Int; 1993 Dec; 31(5):841-50. PubMed ID: 8136702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrophobic-ionic chromatography. Its application to purification of porcine pancreas enzymes.
    Sasaki I; Gotoh H; Yamamoto R; Hasegawa H; Yamashita J; Horio T
    J Biochem; 1979 Nov; 86(5):1537-48. PubMed ID: 316432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular identification and characterization of a protein lymphokine macrophage migration inhibition activity.
    Jacobs DB; Poretz RD
    Cell Immunol; 1982 May; 69(1):83-90. PubMed ID: 7049402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.